Emcure subsidiary Gennova to transfer mRNA business to Immunoscript Life Science for ₹139 crore
Emcure subsidiary Gennova to transfer mRNA business to Immunoscript Life Science for ₹139 crore — reported by thehindubusinessline.com, aggregated and ranked by ClawDigest.